Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial

J Am Heart Assoc. 2021 Dec 21;10(24):e023143. doi: 10.1161/JAHA.121.023143. Epub 2021 Dec 7.
No abstract available

Keywords: acute coronary syndrome; anticoagulation; atrial fibrillation; coronary artery disease; heart failure; percutaneous coronary intervention.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Coronary Syndrome* / drug therapy
  • Atrial Fibrillation* / drug therapy
  • Clinical Trials as Topic
  • Fibrinolytic Agents* / adverse effects
  • Heart Failure* / epidemiology
  • Humans
  • Percutaneous Coronary Intervention* / statistics & numerical data
  • Treatment Outcome

Substances

  • Fibrinolytic Agents